Cardiovascular toxicity in patients with oncohematological diseases: genetic predictors study
The results of this study endorse the possibility of performing a genetic screening before anticancer immunochemotherapy as a future tool for stratifying patients with an oncohematological profile and minimizing CV toxicity. However, further studies are needed to confirm the diagnostic and prognostic role of the above identified genetic variants.
Authors
- Giuseppe Galati (ORCID: https://orcid.org/0000-0002-8001-1249)
- Elena Cavarretta (ORCID: https://orcid.org/0000-0003-0221-6000)
- G. R. Gimatdinova (ORCID: https://orcid.org/0000-0002-7133-1689)
- Mariangela Peruzzi (ORCID: https://orcid.org/0000-0002-9036-8495)
- Alexey Sustretov
- О. Е. Данилова (ORCID: https://orcid.org/0000-0002-4322-0447)
- И. Л. Давыдкин (ORCID: https://orcid.org/0000-0002-4318-4247)
- Olga Germanova (ORCID: https://orcid.org/0000-0003-4833-4563)
- Yuliya Sergeevna Milyutkina
Institutions
- Samara State Medical University (RU)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Minerva Cardiology and Angiology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.23736/s2724-5683.24.06748-6
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39